• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Type o Market segments o Comparison by Type o Hypothyroidism - Market size and forecast 2020-2025 o Hyperthyroidism - Market size and forecast 2020-2025 o Market opportunity by Type • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o AbbVie Inc. o Alvogen ehf o Amgen Inc. o GlaxoSmithKline Plc o Lannett Co. Inc. o Merck KGaA o Pfizer Inc. o RLC Labs Inc. o Viatris Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits Exhibits1: Key Finding 1 Exhibits2: Key Finding 2 Exhibits3: Key Finding 3 Exhibits4: Key Finding 5 Exhibits5: Key Finding 6 Exhibits6: Key Finding 7 Exhibits7: Key Finding 8 Exhibits8: Parent market Exhibits9: Market characteristics Exhibits10: Offerings of vendors included in the market definition Exhibits11: Market segments Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million) Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%) Exhibits14: Five forces analysis 2020 & 2025 Exhibits15: Bargaining power of buyers Exhibits16: Bargaining power of suppliers Exhibits17: Threat of new entrants Exhibits18: Threat of substitutes Exhibits19: Threat of rivalry Exhibits20: Market condition - Five forces 2020 Exhibits21: Type - Market share 2020-2025 (%) Exhibits22: Comparison by Type Exhibits23: Hypothyroidism - Market size and forecast 2020-2025 ($ million) Exhibits24: Hypothyroidism - Year-over-year growth 2020-2025 (%) Exhibits25: Hyperthyroidism - Market size and forecast 2020-2025 ($ million) Exhibits26: Hyperthyroidism - Year-over-year growth 2020-2025 (%) Exhibits27: Market opportunity by Type Exhibits28: Customer landscape Exhibits29: Market share By Geographical Landscape 2020-2025 (%) Exhibits30: Geographic comparison Exhibits31: North America - Market size and forecast 2020-2025 ($ million) Exhibits32: North America - Year-over-year growth 2020-2025 (%) Exhibits33: Europe - Market size and forecast 2020-2025 ($ million) Exhibits34: Europe - Year-over-year growth 2020-2025 (%) Exhibits35: Asia - Market size and forecast 2020-2025 ($ million) Exhibits36: Asia - Year-over-year growth 2020-2025 (%) Exhibits37: ROW - Market size and forecast 2020-2025 ($ million) Exhibits38: ROW - Year-over-year growth 2020-2025 (%) Exhibits39: Key leading countries Exhibits40: Market opportunity By Geographical Landscape ($ million) Exhibits41: Impact of drivers and challenges Exhibits42: Vendor landscape Exhibits43: Landscape disruption Exhibits44: Industry risks Exhibits45: Vendors covered Exhibits46: Market positioning of vendors Exhibits47: Abbott Laboratories - Overview Exhibits48: Abbott Laboratories - Business segments Exhibits49: Abbott Laboratories - Key offerings Exhibits50: Abbott Laboratories - Key customers Exhibits51: Abbott Laboratories - Segment focus Exhibits52: AbbVie Inc. - Overview Exhibits53: AbbVie Inc. - Product and service Exhibits54: AbbVie Inc. - Key offerings Exhibits55: AbbVie Inc. - Key customers Exhibits56: AbbVie Inc. - Segment focus Exhibits57: Alvogen ehf - Overview Exhibits58: Alvogen ehf - Product and service Exhibits59: Alvogen ehf - Key offerings Exhibits60: Alvogen ehf - Key customers Exhibits61: Alvogen ehf - Segment focus Exhibits62: Amgen Inc. - Overview Exhibits63: Amgen Inc. - Business segments Exhibits64: Amgen Inc. - Key offerings Exhibits65: Amgen Inc. - Key customers Exhibits66: Amgen Inc. - Segment focus Exhibits67: GlaxoSmithKline Plc - Overview Exhibits68: GlaxoSmithKline Plc - Business segments Exhibits69: GlaxoSmithKline Plc - Key offerings Exhibits70: GlaxoSmithKline Plc - Key customers Exhibits71: GlaxoSmithKline Plc - Segment focus Exhibits72: Lannett Co. Inc. - Overview Exhibits73: Lannett Co. Inc. - Business segments Exhibits74: Lannett Co. Inc. - Key offerings Exhibits75: Lannett Co. Inc. - Key customers Exhibits76: Lannett Co. Inc. - Segment focus Exhibits77: Merck KGaA - Overview Exhibits78: Merck KGaA - Business segments Exhibits79: Merck KGaA - Key offerings Exhibits80: Merck KGaA - Key customers Exhibits81: Merck KGaA - Segment focus Exhibits82: Pfizer Inc. - Overview Exhibits83: Pfizer Inc. - Business segments Exhibits84: Pfizer Inc. - Key offerings Exhibits85: Pfizer Inc. - Key customers Exhibits86: Pfizer Inc. - Segment focus Exhibits87: RLC Labs Inc. - Overview Exhibits88: RLC Labs Inc. - Product and service Exhibits89: RLC Labs Inc. - Key offerings Exhibits90: RLC Labs Inc. - Key customers Exhibits91: RLC Labs Inc. - Segment focus Exhibits92: Viatris Inc. - Overview Exhibits93: Viatris Inc. - Business segments Exhibits94: Viatris Inc. - Key offerings Exhibits95: Viatris Inc. - Key customers Exhibits96: Viatris Inc. - Segment focus Exhibits97: Currency conversion rates for US$ Exhibits98: Research Methodology Exhibits99: Validation techniques employed for market sizing Exhibits100: Information sources Exhibits101: List of abbreviations

Abbott Laboratories, AbbVie Inc., Alvogen ehf, Amgen Inc., GlaxoSmithKline Plc, Lannett Co. Inc., Merck KGaA, Pfizer Inc., RLC Labs Inc., Viatris Inc.